Issue 2
Novo Nordisk picks AWS as strategic partner for AI drug discovery; London hub to open
Novo Nordisk has selected Amazon Web Services as its strategic partner to accelerate AI-driven drug discovery. According to reports, a London innovation hub will also be launched; the announcement came on 10 August.
Who is affected and how
- pharmaceuticals
- The partnership between a major drugmaker and a cloud provider is a benchmark: companies should assess how ready their own discovery data and computing capacity are for a similar collaboration.
- health IT
- Big pharma demand for cloud-based discovery infrastructure presents an opportunity for suppliers.
Tufts CSDD: AI agents can deliver up to $21 million net value and 82x ROI per drug development programme
A Tufts CSDD analysis finds that AI agents could deliver up to $21 million in net financial value and up to 82x return on investment per drug development programme. An oncology clinical monitoring…
pharmaceuticalsThe figures offer a benchmark for a business case when procuring AI agents for clinical trials, but they should be checked against a company's own programme data.insurance · United StatesAidoc's CARE Body CT Multi-Triage becomes eligible for Medicare new technology add-on payment
Aidoc's CARE Body CT Multi-Triage AI has become eligible for the Medicare New Technology Add-on Payment (NTAP), so health systems that adopt it may receive an extra payment. Analyses also discuss the…
hospital managerThe add-on payment can offset the cost of adopting AI, so US hospitals should check their eligibility.medtech companyThe NTAP example shows that securing a reimbursement pathway needs to be built into the go-to-market plan.health policyIt shows that Medicare is spreading AI tools through payment incentives.regulation · United StatesSeven US states passed healthcare AI rules in 2026, mainly on prior authorization
According to a legislative overview, seven US states enacted new laws in 2026 governing the role of AI in healthcare, with a focus on prior authorization. States are increasingly requiring that…
doctorIt is worth tracking which states require human review, as this matters when appealing denials.hospital managerPatient care and billing processes must be aligned with state requirements.health policyRegulatory fragmentation across states strengthens the case for federal-level harmonisation.regulation · United StatesCalifornia bill would ban AI therapists as states weigh regulating mental health chatbots
California's SB 903 bill would bar companies from marketing chatbots as therapy and restrict AI systems from carrying out therapeutic activity. Analyses debate whether states should regulate AI…
doctorPsychiatric and therapy providers need to watch which AI functions will be allowed to count as therapy.health ITThe marketing and features of mental health chatbots must be aligned with the legal limits.health policyState regulation may fill a gap left by the absence of federal rules.Hungary
More key stories of the week
Some EU AI Act deadlines for healthcare AI and medical devices pushed back to 2028
According to overviews, some EU AI Act deadlines for healthcare AI and medical devices have been pushed back to 2028, while other obligations are already in force. Alongside the MDR/IVDR, the AI Act…
medtech companyCompanies need to assess which AI Act obligations already apply, which are postponed, and which relief measures have not been used.health ITFor software classed as a medical device, the classification (SaMD/MDR) must be reviewed again because of AI functions.health policyThe postponement gives authorities transitional time to prepare and to develop guidelines.case · globalDoctors say patients are self-assessing with AI and may receive dangerous advice
Several reports say patients are increasingly asking AI about their health problems. Doctors, citing in one case patients who received dangerous AI advice, warn that AI does not replace a medical…
doctorClinicians should expect patients who have prepared with AI and make clear what a chatbot is and is not good for.health policyThe risks of AI health information for the public justify a patient-education campaign.research · globalAI clinical decision support is spreading faster than the evidence behind it
A new generation of clinical decision support tools is being rolled out and is changing how evidence is generated. Studies find that physicians are prone to drawing causal illusions from AI-generated…
doctorTreat AI suggestions critically, because physicians too can come to lean on machine classifications.hospital managerDeployment requires validation and monitoring on the hospital's own patient population.health policyEvidence standards will have to be developed to keep pace with the speed of adoption.incidentAI scribe error leaves patient needing record corrected as scribes spread ahead of rules
According to ABC News, an AI scribe's error devastated a patient, who had to have their record corrected. Meanwhile, reports say AI scribes are spreading in GP practices ahead of regulation, and it…
doctorA note generated by an AI scribe must be checked before signing, and patient information must also be sorted out.health ITWhen deploying scribes, the error-correction and privacy process must be defined in advance.health policyRegulation is lagging behind adoption, so guidance is needed.case · globalOpenAI and APA plan youth mental health guidance as experts caution against relying on chatbots
OpenAI and the American Psychological Association (APA) are preparing guidance on teenagers' use of AI, including resources for parents and caregivers. Experts meanwhile warn that chatbots were not…
doctorYoung patients may ask about AI as a source of emotional support, so clinicians should raise the question during visits.health policyGuidance produced through industry and professional collaboration may foreshadow regulation.clinical deploymentNurses demand a say in clinical AI rollout, saying tools arrive without bedside review
Reports say nurses are asking for a seat at the table in decisions on expanding clinical AI, and are also protesting against it. Nurses say hospital AI tools arrive without the bedside review that…
hospital managerBedside user review must be built into the process before AI is deployed.regulation · United StatesWith no uniform rules, liability for healthcare AI errors remains unclear
The FDA has cleared more than 1,500 AI-based medical devices, but the question of liability, meaning who is responsible when one errs, remains unsettled, and there is no uniform rule across states. A…
hospital managerAI procurement contracts should set out the sharing of liability with the vendor separately.doctorIt needs to be clarified what liability follows from following or rejecting an AI recommendation.medtech companyUnclear liability creates contractual and insurance risk for distributors.tool · United StatesOracle launches AI-driven patient portal and brings AI to coding, chart review and dictation
Oracle has launched an AI-driven patient portal and is introducing automated coding, chart review and dictation into healthcare workflows. The news dates from August 12.
doctorAutomated dictation and chart review may reduce the documentation burden, but their output must be checked.health ITOrganisations using Oracle's environment must evaluate the new AI modules and the data-handling requirements.hospital managerAutomated coding may also affect the accuracy of the revenue cycle.drug development · globalAureka raises $100M Series B for AI drug discovery; Isomorphic Labs reportedly secures $2.1 billion
Aureka closed a $100 million Series B round to scale its AI-based drug discovery. According to one report, DeepMind's Isomorphic Labs secured $2.1 billion for AI drug discovery (Aug. 10–11).
pharmaceuticalsCapital flowing to AI-native biotechs increases partnership and competitive pressure.medtech companyFunding dynamics in AI drug discovery also affect the supplier ecosystem.drug development · globalEvotec and Almirall sign AI drug discovery deals as tech capital pushes fail-fast development
Evotec signed an AI drug discovery deal with Odyssey Therapeutics for inflammatory diseases, and Almirall is to use CrystalO's platform to discover ion channel drugs. According to BioSpace, tech…
pharmaceuticalsThe contract and milestone terms of AI-biotech partnerships should also be weighed against the expectations of tech investors.tool · globalChatGPT connects to Apple Health and offers personalized health insights
OpenAI has brought Apple Health data into ChatGPT and launched personalized health insights, raising new questions for clinicians. Experts also warn of the privacy risks of pasting health data into…
doctorPatients may arrive with their own measurement and lab data interpreted by AI; its accuracy is worth checking.health ITIntegrating consumer health data raises privacy and data-management questions.licensing · United StatesLeica Biosystems receives FDA clearances for AI-assisted quality control and digital pathology scanners
Leica Biosystems has received FDA clearance for its AI-assisted quality control solution and its digital pathology scanners. The news was reported on 11 August.
doctorPathologists gain a wider range of FDA-cleared digital workflow tools.hospital managerA new cleared option is available when planning digital pathology investments.medtech companyCleared AI quality control sets a competitive benchmark in the pathology scanner market.